Hamilton Lane Incorporated header image

Hamilton Lane Incorporated

HLNE

Equity

ISIN US4074971064 / Valor 35590797

NASDAQ (2024-12-26)
USD 154.00+2.27%

Hamilton Lane Incorporated
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Hamilton Lane Incorporated is a prominent investment management firm specializing in private markets. Listed on the Nasdaq under the ticker HLNE, the company has established itself as a leader in offering a wide range of investment solutions and products across private equity, private credit, real estate, and infrastructure. Its services cater to institutional and individual investors worldwide, aiming to provide access to opportunities in private markets that are often less accessible or understood. Hamilton Lane distinguishes itself through its comprehensive market overviews and educational initiatives, such as the "Truths Revealed" series, which seeks to demystify private market investing and correct common misconceptions. This focus on transparency and education, combined with its investment expertise, underscores Hamilton Lane's commitment to advancing its clients' interests in the complex landscape of private markets.

Summarized from source with an LLMView SourceSector: Finance

Latest Results (24.12.2024):

Assets Under Management

Hamilton Lane Incorporated reported total assets under management of $131.4 billion for the second fiscal quarter ended September 30, 2024. This represents a year-over-year increase of $12.2 billion. Additionally, fee-earning assets under management rose by $8.3 billion, reaching a total of $69.7 billion.

Revenue Growth

For the second fiscal quarter of 2025, Hamilton Lane Incorporated achieved management and advisory fees totaling $119.8 million. This marks a 10% growth compared to the same period in the previous year, highlighting the firm's continued expansion in its core business operations.

Carried Interest

The unrealized carried interest balance for Hamilton Lane Incorporated reached approximately $1.3 billion by the end of the second fiscal quarter of 2025. This figure represents a 9% increase from the prior year period, indicating strong performance in the firm's investment strategies.

Earnings Per Share

Hamilton Lane Incorporated reported a GAAP earnings per share (EPS) of $1.37 for the second fiscal quarter of 2025. The company achieved a GAAP net income of $55.0 million during this period, reflecting its solid financial performance.

Dividend Announcement

For the second fiscal quarter of 2025, Hamilton Lane Incorporated declared a quarterly dividend of $0.49 per share of Class A common stock. The dividend is payable on January 7, 2025, to shareholders of record as of December 16, 2024. The company targets a full-year dividend of $1.96, representing a 10% increase from the previous fiscal year.

Summarized from source with an LLMView Source

Key figures

34.3%1Y
48.5%3Y
151%5Y

Performance

29.2%1Y
33.0%3Y
37.6%5Y

Volatility

Market cap

6290 M

Market cap (USD)

Daily traded volume (Shares)

170,970

Daily traded volume (Shares)

1 day high/low

155.19 / 149.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Lufax Holding Limited
Lufax Holding Limited Lufax Holding Limited Valor: 131038783
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.67%USD 2.43
Corpay Inc
Corpay Inc Corpay Inc Valor: 133858012
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.28%USD 345.28
Kennedy-Wilson Holdings Inc
Kennedy-Wilson Holdings Inc Kennedy-Wilson Holdings Inc Valor: 10751367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 10.03
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MoonLake Immunotherapeutics Valor: 118139749
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.28%USD 54.40
Lionsgate Studios Corp
Lionsgate Studios Corp Lionsgate Studios Corp Valor: 135198315
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.13%USD 7.24
Labcorp Holdings Inc
Labcorp Holdings Inc Labcorp Holdings Inc Valor: 134866476
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.68%USD 231.06
KK Astroscale Holdings
KK Astroscale Holdings KK Astroscale Holdings Valor: 135002283
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.70%JPY 809.00
SAMTY HOLDINGS KK
SAMTY HOLDINGS KK SAMTY HOLDINGS KK Valor: 135002284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%JPY 3,295.00
Belite Bio Incorporation
Belite Bio Incorporation Belite Bio Incorporation Valor: 118450378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.53%USD 62.95
Sharkninja Incorporation
Sharkninja Incorporation Sharkninja Incorporation Valor: 128046052
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.65%USD 98.54